Literature DB >> 3119205

Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.

E M Rankin1, C Harvey, R K Knight, R D Rubens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3119205

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Continuous versus intermittent prednimustine treatment of non-Hodgkin's lymphoma.

Authors:  T Hatschek; L Baldetorp; J Carstensen; L Håkansson; T Möller; B Nilsson; B Termander
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

2.  Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity.

Authors:  M E O'Brien; D M Eccles; S G Allen; G Knight; A Rodger; U Chetty; J F Smyth; R C Leonard
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.